A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis

Wenwen Xu(Soochow University), Shuang Ye(Little Swan (China)), Danting Zhang(National Clinical Research Center for Digestive Diseases), Wanlong Wu(Shanghai Jiao Tong University), Xiaodong Wang, Zhiwei Chen(Shanghai Jiao Tong University), Kaiwen Wang(Fudan University), Yu Zheng(Shanghai Jiao Tong University), Xinwei Tao(Siemens Healthcare (United States)), Jiangfeng Zhao(Shanghai Jiao Tong University)
Scientific Reports
August 23, 2021
10.1038/s41598-021-96292-w
Cited by 35

Related Papers

Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
|Clinical Reviews in Allergy & Immunology|2021|210
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
|Nature Communications|2022|112
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
|Patient Preference and Adherence|2018|111
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease
|Lara D. Veeken|2018|60
Effectiveness and safety of tofacitinib<i>versus</i>calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study
|European Respiratory Journal|2025|48